Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair

British Journal of Dermatology

Volumn 166, Issue 6, 2012, Pages 1245-1254

  De Koning, H D ^a,b   Van Den Bogaard, E H ^a,b   Bergboer, J G M ^a,b   Kamsteeg, M ^a,b   Van Vlijmen Willems, I M J J ^a   Hitomi, K ^c   Henry, J ^d,e,f   Simon, M ^d,e,f   Takashita, N ^g   Ishida Yamamoto, A ^g   Schalkwijk, J ^a,b   Zeeuwen, P L J M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NAGOYA UNIVERSITY   (Japan)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e CNRS UMR5165   (France)

^f INSERM   (France)

^g ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN V; CORNIFIED ENVELOPE STRUCTURAL PROTEIN; CYSTATIN M; DODECYL SULFATE SODIUM; ENVOPLAKIN; FILAGGRIN; FILAGGRIN 2; HORNERIN; INVOLUCRIN; KALLIKREIN 5; KERATINOCYTE DIFFERENTIATION REGULATING PROTEIN; LATE CORNIFIED ENVELOPE 2B; LATE CORNIFIED ENVELOPE 3A; LATE CORNIFIED ENVELOPE 5A; LORICRIN; MEMBRANE PROTEIN; MESSENGER RNA; PERIPLAKIN; REPETIN; SMALL PROLINE RICH PROTEIN 1; SMALL PROLINE RICH PROTEIN 2; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; TRANSGLUTAMINASE 1; TRANSGLUTAMINASE 3; TRANSGLUTAMINASE 5; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CELL REGENERATION; CLINICAL ARTICLE; CLINICAL SKIN REACTION; CONTACT DERMATITIS; CONTROLLED STUDY; DOWN REGULATION; ELECTRON MICROSCOPY; EPIDERMIS; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MEMBRANE DAMAGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SKIN BARRIER DYSFUNCTION; SKIN BIOPSY; SKIN CORNIFICATION; SKIN EXAMINATION; SKIN EXFOLIATION; STRATUM CORNEUM; UPREGULATION;

BIOPSY; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CHRONIC DISEASE; CORNIFIED ENVELOPE PROLINE-RICH PROTEINS; DERMATITIS, ATOPIC; DOWN-REGULATION; EPIDERMIS; HUMANS; KERATINOCYTES; PSORIASIS; RNA, MESSENGER; TRANSGLUTAMINASES; WOUND HEALING;

EID: 84861594725     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10885.x     Document Type: Article

References (50)

1. Huber M, Rettler I, Bernasconi K, et al. Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 1995; 267: 525-8.
2. Russell LJ, DiGiovanna JJ, Rogers GR, et al. Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nat Genet 1995; 9: 279-83.
3. Chavanas S, Bodemer C, Rochat A, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000; 25: 141-2.
4. Kilic G, Guler N, Ones U, et al. Netherton syndrome: report of identical twins presenting with severe atopic dermatitis. Eur J Pediatr 2006; 165: 594-7.
5. Rabinowitz LG, Esterly NB,. Atopic dermatitis and ichthyosis vulgaris. Pediatr Rev 1994; 15: 220-6.
6. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-6.
7. de Cid R, Riveira-Munoz E, Zeeuwen PL, et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 2009; 41: 211-15.
8. Hollox EJ, Huffmeier U, Zeeuwen PL, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008; 40: 23-5.
9. Li M, Wu Y, Chen G, et al. Deletion of the late cornified envelope genes LCE3C and LCE3B is associated with psoriasis in a Chinese population. J Invest Dermatol 2011; 131: 1639-43.
10. Riveira-Munoz E, He SM, Escaramis G, et al. Meta-analysis confirms the LCE3C-LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6. J Invest Dermatol 2011; 131: 1105-9.
11. Guttman-Yassky E, Nograles KE, Krueger JG,. Contrasting pathogenesis of atopic dermatitis and psoriasis-part I: clinical and pathologic concepts. J Allergy Clin Immunol 2011; 127: 1110-18.
12. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
13. Kalinin AE, Kajava AV, Steinert PM,. Epithelial barrier function: assembly and structural features of the cornified cell envelope. Bioessays 2002; 24: 789-800.
14. Candi E, Schmidt R, Melino G,. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328-40.
15. Caubet C, Jonca N, Brattsand M, et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 2004; 122: 1235-44.
16. Blanpain C, Fuchs E,. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 2009; 10: 207-17.
17. Gerritsen MJ, van Erp PE, van Vlijmen-Willems IM, et al. Repeated tape stripping of normal skin: a histological assessment and comparison with events seen in psoriasis. Arch Dermatol Res 1994; 286: 455-61.
18. Torma H, Lindberg M, Berne B,. Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo. J Invest Dermatol 2008; 128: 1212-19.
19. Torma H, Berne B,. Sodium lauryl sulphate alters the mRNA expression of lipid-metabolizing enzymes and PPAR signalling in normal human skin in vivo. Exp Dermatol 2009; 18: 1010-15.
20. de Koning HD, Kamsteeg M, Rodijk-Olthuis D, et al. Epidermal expression of host response genes upon skin barrier disruption in normal skin and uninvolved skin of psoriasis and atopic dermatitis patients. J Invest Dermatol 2011; 131: 263-6.
21. van Ruissen F, Jansen BJ, de Jongh GJ, et al. A partial transcriptome of human epidermis. Genomics 2002; 79: 671-8.
22. de Jongh GJ, Zeeuwen PL, Kucharekova M, et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 2005; 125: 1163-73.
23. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402-8.
24. van Duijnhoven JL, Schalkwijk J, Kranenborg MH, et al. MON-150, a versatile monoclonal antibody against involucrin: characterization and applications. Arch Dermatol Res 1992; 284: 167-72.
25. Bergboer JG, Tjabringa GS, Kamsteeg M, et al. Psoriasis risk genes of the late cornified envelope-3 group are distinctly expressed compared with genes of other LCE groups. Am J Pathol 2011; 178: 1470-7.
26. Hsu CY, Henry J, Raymond AA, et al. Deimination of human filaggrin-2 promotes its proteolysis by calpain 1. J Biol Chem 2011; 286: 23222-33.
27. Henry J, Hsu CY, Haftek M, et al. Hornerin is a component of the epidermal cornified cell envelopes. FASEB J 2011; 25: 1567-76.
28. Zeeuwen PL, van Vlijmen-Willems IM, Cheng T, et al. The cystatin M/E-cathepsin L balance is essential for tissue homeostasis in epidermis, hair follicles, and cornea. FASEB J 2010; 24: 3744-55.
29. Hiiragi T, Sasaki H, Nagafuchi A, et al. Transglutaminase type 1 and its cross-linking activity are concentrated at adherens junctions in simple epithelial cells. J Biol Chem 1999; 274: 34148-54.
30. Sugimura Y, Hosono M, Kitamura M, et al. Identification of preferred substrate sequences for transglutaminase 1-development of a novel peptide that can efficiently detect cross-linking enzyme activity in the skin. FEBS J 2008; 275: 5667-77.
31. Igawa S, Kishibe M, Murakami M, et al. Tight junctions in the stratum corneum explain spatial differences in corneodesmosome degradation. Exp Dermatol 2011; 20: 53-7.
32. Zhang XJ, Huang W, Yang S, et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet 2009; 41: 205-10.
33. Ghadially R, Reed JT, Elias PM,. Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 1996; 107: 558-64.
34. Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest 2004; 113: 651-7.
35. Nickoloff BJ, Nestle FO,. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004; 113: 1664-75.
36. Segre JA,. Epidermal barrier formation and recovery in skin disorders. J Clin Invest 2006; 116: 1150-8.
37. van der Valk PG, Maibach HI,. A functional study of the skin barrier to evaporative water loss by means of repeated cellophane-tape stripping. Clin Exp Dermatol 1990; 15: 180-2.
38. Sextius P, Marionnet C, Bon FX, et al. Large scale study of epidermal recovery after stratum corneum removal: dynamics of genomic response. Exp Dermatol 2010; 19: 259-68.
39. Le TK, De Mon P, Schalkwijk J, van der Valk PG,. Effect of a topical corticosteroid, a retinoid and a vitamin D3 derivative on sodium dodecyl sulphate induced skin irritation. Contact Dermatitis 1997; 37: 19-26.
40. Ekanayake-Mudiyanselage S, Aschauer H, Schmook FP, et al. Expression of epidermal keratins and the cornified envelope protein involucrin is influenced by permeability barrier disruption. J Invest Dermatol 1998; 111: 517-23.
41. Jakasa I, Koster ES, Calkoen F, et al. Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations. J Invest Dermatol 2011; 131: 540-2.
42. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120: 150-5.
43. Vermeij WP, Backendorf C,. Skin cornification proteins provide global link between ROS detoxification and cell migration during wound healing. PLoS ONE 2010; 5: e11957.
44. Demerjian M, Hachem JP, Tschachler E, et al. Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2. Am J Pathol 2008; 172: 86-97.
45. Candi E, Melino G, Lahm A, et al. Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processing. J Biol Chem 1998; 273: 13693-702.
46. Wu Z, Hansmann B, Meyer-Hoffert U, et al. Molecular identification and expression analysis of filaggrin-2, a member of the S100 fused-type protein family. PLoS ONE 2009; 4: e5227.
47. Wu Z, Harder J, Bartels J, et al. A novel peptide antibiotic derived from human hornerin. Exp Dermatol 2007; 16: 226 (Abstract).
48. Kalia YN, Pirot F, Guy RH,. Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. Biophys J 1996; 71: 2692-700.
49. Bergboer JG, Zeeuwen PL, Irvine AD, et al. Deletion of late cornified envelope 3B and 3C genes is not associated with atopic dermatitis. J Invest Dermatol 2010; 130: 2057-61.
50. Elias PM,. Skin barrier function. Curr Allergy Asthma Rep 2008; 8: 299-305.